To confirm the chemosensitizing activity of jorunnamycin A in CSCs of human lung cancer cells, annexin V-FITC/propidium iodide (PI) staining and subsequent flow cytometry was performed to characterize mode of cell death [47]. The gene discussed is ANXA5; the disease is lung cancer.